8-K - Atrium Therapeutics, Inc. (0002093101) (Filer)
Published . Updated .
8-K - Atrium Therapeutics filed an 8-K with the SEC on Oct 27 (a notice of a material company event).
Directly affected
- RNA Atrium Therapeutics+1.0% 17d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Atrium Therapeutics belongs to, so it often moves with news about it.
- LLY Eli Lilly and+21.6% 30d
Eli Lilly and is a peer of Atrium Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson+1.5% 30d
Johnson & Johnson is a peer of Atrium Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+11.4% 30d
AbbVie is a peer of Atrium Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck+3.2% 18d
Merck is a peer of Atrium Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories+3.1% 30d
Abbott Laboratories is a peer of Atrium Therapeutics in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| RNA | -0.62% | +1.25% | base | +3.24% | +4.73% | +2.74% | +3.24% |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| LLYNo price data for this ticker | — | — | — | — | — | — | — |
| JNJNo price data for this ticker | — | — | — | — | — | — | — |
| ABBVNo price data for this ticker | — | — | — | — | — | — | — |
| MRKNo price data for this ticker | — | — | — | — | — | — | — |
| ABTNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-27 AccNo: 0001193125-26-432949 Size: 182 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Atrium Therapeutics (RNA) since this story, compared with the market
Since the first closing price after “8-K - Atrium Therapeutics, Inc. (0002093101) (Filer),” Atrium Therapeutics (RNA) is -1.31%.
| Company | When | Move | Status |
|---|---|---|---|
| Atrium Therapeutics (RNA) | that day | +3.24% | final price |
| Atrium Therapeutics (RNA) | the next day | +4.73% | final price |
| Atrium Therapeutics (RNA) | two days later | +2.74% | final price |
| Atrium Therapeutics (RNA) | three days later | +3.24% | final price |
| Atrium Therapeutics (RNA) | three days earlier | +1.25% | final price |
| Atrium Therapeutics (RNA) | five days earlier | -0.62% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 53 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 32 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 49 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 53 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 43 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 53 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought AbbVie (ABBV), worth $50,001 - $100,000 on 31 Jul 2026. That is 88 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 33 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 69 days before publication. Filed 9 Sep 2026. View the filing.
- Donald J Trump, an executive branch official, sold Merck (MRK), worth $250,001 - $500,000 on 31 Jul 2026. That is 88 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Pete Sessions sold Abbott Laboratories (ABT) (held by a spouse), worth $50,001 - $100,000 on 2 Oct 2026. That is 25 days before publication. Filed 27 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Abbott Laboratories (ABT), worth $1,001 - $15,000 on 18 Sep 2026. That is 39 days before publication. Filed 12 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - Atrium Therapeutics, Inc. (0002093101) (Filer)”
Companies tied to this story
- RNA Atrium Therapeutics
In “8-K - Atrium Therapeutics, Inc. (0002093101) (Filer),” Atrium Therapeutics (RNA) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> RNA
How “8-K - Atrium Therapeutics, Inc. (0002093101) (Filer)” reaches Atrium Therapeutics (RNA)
The 27 Oct 2026 story “8-K - Atrium Therapeutics, Inc. (0002093101) (Filer)” names Atrium Therapeutics (RNA) because of this story.
Atrium Therapeutics (RNA) is on the page because SEC 8-K filing -> direct issuer disclosure -> RNA
Dates in the story, and the Atrium Therapeutics (RNA) price range
RNA traded between 7.50 and 8.57 across 17 sessions. The latest close on file is 8.31.
How solid “8-K - Atrium Therapeutics, Inc. (0002093101) (Filer)” looks
14 out of 100
“8-K - Atrium Therapeutics, Inc. (0002093101) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.